Recruited 6 months ago to lead the US vaccine strategy, Belgian-Moroccan Moncef Slaoui resigned Tuesday January 12 at the request of the Biden team. Dr Slaoui will step down in a month, after leading the unprecedented effort of the US government to develop a safe and effective vaccine against Covid-19 before the end of 2020. The Moroccan-American immunologist had previously announced his intention to resign a once two vaccines and two therapies for Covid-19 were on the market, a goal that was achieved last month with the approval by U.S. health officials of Moderna and Pfizer’s vaccines. Although the vaccination campaign has not been as rapid as expected in the United States, the speed of vaccine development, overseen by Dr Slaoui, has exceeded expectations. Two vaccines have been authorized in the United States with 95% effectiveness against the virus in less than a year.
Trending
- Senegal: a government of 30 ministers without the Pastef (list)
- The strategic and managerial vision of the new leadership of Gécamines led by Baraka Kabemba
- Burkina Faso: Under the sun of the Popular Progressive Revolution, the state as a shareholder, a competitor to the private sector
- Dividends 2025: Nearly 121 billion CFA francs for the shareholders of Orange Côte d’Ivoire group
- Indebtedness is a profession: what Africa can learn from Benin (Finactu)
- Wave Mobile Money highlights youth, innovation, and financial inclusion at the Basketball Africa League Business Brunch in Kigali
- Benin: Fiacre Vidjingninou, the new spokesperson of the Marina Palace
- Proceedings of the African Development Bank (AfDB) Assemblies: the call from Brazzaville
